Author

Pengfei Guo

Observed name: Pengfei Guo Guo

Institutions: Shenzhen University, Chinese Academy of Medical Sciences & Peking Union Medical College

Observed institutions: Shenzhen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Chinese Materia Medica

ORCID: 0000-0002-1085-0418

Observed ORCID: 0000-0002-1085-0418

OpenAlex ID: A5100316702

Neuroinflammation inhibition and neuroprotective effects of purpurin, a potential anti‐AD compound, screened via network proximity and gene enrichment analyses

2024 · Jun Zhao, Pengfei Guo, et al. · Phytotherapy Research · 8

Combination of RNA-seq and proteomics reveals the mechanism of DL0410 treatment in APP/PS1 transgenic mouse model of Alzheimer's disease

2024 · Baoyue Zhang, Jun Zhao, et al. · Biomedicine & Pharmacotherapy · 2

Effect of DL0410 and tetrahydrocurcumin (LG0367) alone and in combination on learning and memory in vascular dementia

2026 · Pengfei Guo, Jun Zhao, et al. · European Journal of Pharmacology · 1

A network medicine and rank product-based framework for compound prioritization in Alzheimer’s disease: application to

2026 · Pengfei Guo, Shengquan Hu, et al. · Research Square

Isorhapontigenin, a Potential Anti-Ad Natural Product by Multiple Pathways, Discovered Via Network Proximity and Gene Enrichment Analyses

2025 · Pengfei Guo Guo, Pengfei Guo, et al. · SSRN Electronic Journal

Works count: 5

Citation count: 11

H-index: 2

I10-index: